glp 1 dietician Warning: Nutrition is vital when taking GLP-1 weight loss drugs Webinar: Eating in the Age

as excess energy accumulates, white adipose tissue (WAT) cells undergo abnormal, hypertrophic growth, leading to poor blood supply (hypoxia), macrophage infiltration, and systemic inflammation

Retrieved March 10, 2026, from After adding coverage of GLP-1s for weight loss August 1, 2024, North Carolina Medicaid reversed course to end coverage effective October 1, 2025, due to North Carolina Department of Health and Human Services (DHHS) anticipated shortfalls in state funding prompted by budget disagreements in the North Carolina General Assembly

Medical history: Relevant history related to metabolic health, insulin resistance, or other conditions that might make GLP-1 therapy appropriate

Despite the major success of Ozempic and Wegovy, analysts are mixed on Novo Nordisk going forward